NCT04195776View on ClinicalTrials.gov

Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
HIV/AIDSHIV Prevention
Interventions
DRUG

Tenofovir Douche

660 mg TFV in 125 mL hypo-osmolar solution

Trial Locations (1)

21287

Johns Hopkins University, Baltimore

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

CONRAD

OTHER

lead

Johns Hopkins University

OTHER